BMS-247550 in Treating Patients With Stage IV Melanoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of BMS-247550 in treating patients who have stage
IV melanoma. Drugs used in chemotherapy use different ways to stop tumor cells from dividing
so they stop growing or die